The Claim
Apigenin does not significantly alter the expression levels of the lipolytic genes ATGL, HSL, and MGL in mouse 3T3-L1 adipocytes, and its anti-adipogenic effect is not mediated by increased fat breakdown.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin does not change the activity of genes involved in breaking down fat in mouse fat cells, meaning its ability to reduce fat cell formation does not come from increasing fat breakdown.
See the scientific wording
Apigenin has no significant effect on the expression of lipolytic genes (ATGL, HSL, MGL) in mouse 3T3-L1 adipocytes, indicating its anti-adipogenic effect is not mediated through increased fat breakdown.
Apigenin turns on a cellular energy sensor called AMPK, which shuts down the master switch for fat cell formation, preventing new fat cells from developing and stopping them from storing fat.
What the research says
1 studyStudy: Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells.
Apigenin doesn’t make fat cells burn more fat — it just stops them from making more fat in the first place. So it reduces fat by blocking fat creation, not by speeding up fat breakdown.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.